Randomized phase III study to evaluate the impact of secondary cytoreductive surgery in recurrent ovarian cancer: Final analysis of AGO DESKTOP III/ENGOT-ov20 - Du Bois, A; Sehouli, J; Vergote, I (J Clin Oncol, 2020)